Navigation Links
Chemo Pills Effective, But Patients May Skip Doses
Date:1/17/2013

THURSDAY, Jan. 17 (HealthDay News) -- Although chemotherapy pills are able to target certain cancers better than traditional intravenous drugs, some patients have trouble taking them, according to new research.

A study from researchers at Michigan State University found that more than 40 percent of patients took the wrong number of pills or skipped doses altogether. They noted severe side effects and complicated instructions for some oral prescriptions often are to blame.

"Prescriptions for some oral pills have complex instructions," study leader Sandra Spoelstra, an assistant professor of nursing, said in a university news release. "Some of them require patients to take pills several times a day or cycle their doses, taking one pill a day for three weeks, then stopping for a week before starting again. And some patients take two types of pills to treat their cancer or have multiple medications for other chronic conditions. It can be very complicated."

The researchers noted that chemotherapy pills often cause pain, severe nausea, vomiting, diarrhea, fatigue and skin reactions. Patients may skip doses of their medications to avoid these negative side effects, making the pills ineffective.

In the study, which was published recently in the journal Cancer Nursing, the researchers divided the participants into three groups. The first group included patients who had help deciphering their prescriptions from an automated calling system developed at the university. Patients in the second group received the automated calls as well as follow-up calls from nurses providing them with tips on how to stick to their treatment plan. The third group received the automated calls and the follow-up tips from nurses, as well as advice on how to manage their symptoms.

The study found that patients in all three groups said their symptoms had eased by the end of the study. The researchers noted that the automated calls alone were just as effective as when they were offered with tips from nurses.

The study's authors concluded that the automated call system could be an inexpensive way to help patients on chemotherapy pills follow through on their treatment plan correctly. They said nurses should carefully explain oral chemotherapy instructions. The researchers added that their findings could provide a foundation for more research to help improve oral chemotherapy.

"It's cutting-edge treatment, but we don't know enough about it yet," said the study's co-author, Barbara Given, associate dean for research in the university's College of Nursing. "People think if they had a life-threatening disease and their doctor recommended treatment, they'd follow the recommendations. But it's really not that simple."

More information

The U.S. National Cancer Institute provides more information on cancer drugs.

-- Mary Elizabeth Dallas

SOURCE: Michigan State University, news release, Jan. 10, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New model may help predict response to chemotherapy for colorectal cancer
2. Paired CT scans catch chemo-killing of liver tumors in real time
3. UAlberta medical researchers discover new potential chemotherapy
4. Intensified chemotherapy shows promise for children with very high risk form of leukemia
5. UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy
6. Chemo Brain May Occur Before Treatment Even Starts
7. For Aggressive Breast Cancer, Chemo May Work Better in the Young
8. Immune system kill switch could be target for chemotherapy and infection recovery
9. Chemo May Extend Survival After Breast Cancers Return
10. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
11. Improving chemotherapy effectiveness by acting on the immune system
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemo Pills Effective, But Patients May Skip Doses
(Date:5/26/2017)... , ... May 26, 2017 , ... Yisrayl Hawkins, Pastor ... publication this week that is focusing on the Peace Agreements being discussed by President ... East sprint in a race to try to speed up peace talks in the ...
(Date:5/26/2017)... ... ... Lowe acts as host and helps educate and inform the public using the “Informed” ... reconnect with America as it explores some of the best places to hike and ... inventive new place for a family vacation, and have discovered hiking. Many will agree ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: ... the creation of published author Laura Weigel Douglas, an avid reader who lives in ... house that sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... recipient of proceeds from its 14th Annual Clays for Kids fundraiser, to be ... 30, Bennett, Colorado. , As part of BluSky’s partnership with The Adoption ...
(Date:5/26/2017)... ... ... “Cactus Jack: Against All Odds”: the story of Coach Cactus Jack and the impact ... the creation of published author, Walter Hubbard, a retired wildlife and fisheries biologist and ... Walter. Walter and Jane have three adult children and a granddaughter. Walter ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... May 23, 2017  Leaf Healthcare, recognized for ... devices for pressure ulcer prevention, will unveil its ... of Critical Care Nurses, National Teaching Institute and ... The Leaf Patient Monitoring System is the ... hospital environment.  The system seamlessly tracks patient movement ...
(Date:5/22/2017)... , May 22, 2017  As the specialty ... whole continue to make the revolutionary shift from ... important for ensuring positive patient outcomes and shaping ... are shifting focus away from clinical trials and ... of long-term specialty drug therapy utilization in precise ...
(Date:5/18/2017)... , May 17, 2017  Bayer announced today that ... will be presented at the 53 rd Annual ... taking place June 2-6 in Chicago ... ASCO span prostate, colorectal, liver and thyroid cancers, as ... the Phase II CHRONOS-1 trial of copanlisib in patients ...
Breaking Medicine Technology: